Robert Filadoro

Sr. Director Tax and Treasury at Alnylam Pharmaceuticals - Cambridge, Massachusetts, US

Robert Filadoro's Colleagues at Alnylam Pharmaceuticals
Tim Buck

Director, Lumasiran Global Marketing

Contact Tim Buck

Tyler Carlage

Associate Director, Analytical Development

Contact Tyler Carlage

Christopher Weinert

Associate Director - Combination Product

Contact Christopher Weinert

Holly Maier

Director, Regulatory Affairs

Contact Holly Maier

Christopher Fuith

Senior Manager, Medical Device & Combination Product Development

Contact Christopher Fuith

Samuel Rigourd

Senior Director Regulatory Affairs

Contact Samuel Rigourd

View All Robert Filadoro's Colleagues
Robert Filadoro's Contact Details
HQ
(617) 551-8200
Location
Greater Boston Area
Company
Alnylam Pharmaceuticals
Robert Filadoro's Company Details
Alnylam Pharmaceuticals logo, Alnylam Pharmaceuticals contact details

Alnylam Pharmaceuticals

Cambridge, Massachusetts, US • 2460 Employees
SaaS

ALNYLAM IS LEADING THE RNAi REVOLUTION™ Alnylam is a leading independent biopharmaceutical company and the pioneer in RNA interference (RNAi) therapeutics – a revolutionary approach to treating diseases which “silences” the genes that cause or contribute to them. Founded in 2002 by a group of distinguished researchers and biotech leaders, Alnylam’s work over more than two decades has yielded the critical breakthroughs and advancements that have made the field of (RNAi) therapeutics possible. In 2018, our first commercial medicine, and the world’s first RNAi therapeutic was approved. Since then, four more Alnylam-developed medicines have been approved and we’re hard at work developing new therapies to treat both rare and prevalent diseases. We are a global and diverse company of 2,500+ people. We pride ourselves on fostering a fun, inclusive and dynamic work environment where employees can recognize their fullest potential. That's why we’re consistently ranked as a top employer by The Boston Globe (2015-23), Science Magazine (2018-23), Fast Company (Best Workplaces for Innovators 2020-23) and LinkedIn (2024). We are based in Cambridge, Massachusetts (U.S.), with offices throughout North America, Europe, Asia, and South America. See our social media community guidelines: https://bit.ly/2FcRhJy. Please note: If you wish to report an adverse event or product complaint, please email medinfo@alnylam.com or you may call us using the following telephone numbers: for North America, 877.ALNYLAM (877.256.9526), for Europe, +31 20 369 7861

Rna Therapeutics Innovative Treatments Ocular Disease Treatment
Details about Alnylam Pharmaceuticals
Frequently Asked Questions about Robert Filadoro
Robert Filadoro currently works for Alnylam Pharmaceuticals.
Robert Filadoro's role at Alnylam Pharmaceuticals is Sr. Director Tax and Treasury.
Robert Filadoro's email address is ***@alnylam.com. To view Robert Filadoro's full email address, please signup to ConnectPlex.
Robert Filadoro works in the SaaS industry.
Robert Filadoro's colleagues at Alnylam Pharmaceuticals are Tim Buck, Tyler Carlage, Christopher Weinert, Holly Maier, Chris Sullivan, Christopher Fuith, Samuel Rigourd and others.
Robert Filadoro's phone number is (617) 551-8200
See more information about Robert Filadoro